Funding for this research was provided by:
National Natural Science Foundation of China (72174142)
Haisco Pharmaceutical Group
Article History
Accepted: 21 March 2024
First Online: 20 April 2024
Declarations
:
: LC contributed to the study design, data collection, data analysis, interpretation, and manuscript drafting and review. HZ contributed to data collection, data analysis, and manuscript drafting. TH contributed to the interpretation and review. SX contributed to the study design, data analysis, interpretation, and review. All authors approved the final version of the manuscript before its submission.
: The authors declare no conflicts of interest.
: This study was funded by the National Natural Science Foundation of China (Grant no. 72174142) and Haisco Pharmaceutical Group.
: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
: The study was approved by the Ethics Committee of Tianjin University (No. TJUE-2020-185), China.
: The datasets generated and analyzed during the current study are not publicly available owing to the informed consent rules with respondents included in this study.